Azathioprine, 6-mercaptopurine and thiopurine s-methyltransferase levels in inflammatory bowel disease: what is current clinical practice?

被引：0
|
作者：
Siriwardana, A. S. [1 ]
Koo, J. H. [1 ,2 ]
Ng, W. S. W. [1 ,2 ]
Connor, S. J. [1 ,2 ]
机构：
[1] Univ New S Wales, Sydney, NSW 2052, Australia
[2] Liverpool Hosp, Dept Gastroenterol, Liverpool, Merseyside, England
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A311 / A312
页数：2
相关论文
共 50 条
  • [31] No predictive value of thiopurine S-methyltransferase genotyping for adverse events in inflammatory bowel disease patients established on azathioprine
    Derijks, LJJ
    Curvers, WL
    Hooymans, PM
    van Deventer, SJH
    Hommes, DW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) : 105 - 105
  • [32] Genetic polymorphisms of the thiopurine S-methyltransferase (TPMT) locus in patients treated with azathioprine for inflammatory bowel disease.
    Rietdijk, ST
    Bartelsman, J
    Hommes, DW
    Vogels, E
    Reitsma, PH
    Van Deventer, SJH
    GASTROENTEROLOGY, 2001, 120 (05) : A622 - A622
  • [33] Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease:: impact of thiopurine S-methyltransferase polymorphism
    Schwab, M
    Schäffeler, E
    Marx, C
    Fischer, C
    Lang, T
    Behrens, C
    Gregor, M
    Eichelbaum, M
    Zanger, UM
    Kaskas, BA
    PHARMACOGENETICS, 2002, 12 (06): : 429 - 436
  • [34] Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine
    Evans, WE
    Hon, YY
    Bomgaars, L
    Coutre, S
    Holdsworth, M
    Janco, R
    Kalwinsky, D
    Keller, F
    Khatib, Z
    Margolin, J
    Murray, J
    Quinn, J
    Ravindranath, Y
    Ritchey, K
    Roberts, W
    Rogers, ZR
    Schiff, D
    Steuber, C
    Tucci, F
    Kornegay, N
    Krynetski, EY
    Relling, MV
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) : 2293 - 2301
  • [35] Clinical manifestations of thiopurine S-methyltransferase variants in Korean paediatric patients with inflammatory bowel disease
    Kim, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S304 - S305
  • [36] 6-Mercaptopurine and inflammatory bowel disease
    Madrigal, EJD
    Garcia, LY
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (06) : 455 - 456
  • [37] Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia
    Ando, M
    Ando, Y
    Hasegawa, Y
    Sekido, Y
    Shimokata, K
    Horibe, K
    PHARMACOGENETICS, 2001, 11 (03): : 269 - 273
  • [38] Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance
    Yates, CR
    Krynetski, EY
    Loennechen, T
    Fessing, MY
    Tai, HL
    Pui, CH
    Relling, MV
    Evans, WE
    ANNALS OF INTERNAL MEDICINE, 1997, 126 (08) : 608 - +
  • [39] Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease
    Ramakrishna, J
    Langhans, N
    Calenda, K
    Grand, RJ
    Verhave, M
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1996, 22 (03): : 296 - 302
  • [40] Tolerability of 6-mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease
    Lees, C. W.
    Maan, A. K.
    Hansoti, B.
    Penman, I. D.
    Shand, A. G.
    Palmer, K. R.
    Arnott, I. D. R.
    Satsangi, J.
    GUT, 2007, 56 : A24 - A24
12345